Page last updated: 2024-08-24

di-halo and biguanides

di-halo has been researched along with biguanides in 1 studies

*Biguanides: Derivatives of biguanide (the structure formula HN(C(NH)NH2)2) that are primarily used as oral HYPOGLYCEMIC AGENTS for the treatment of DIABETES MELLITUS, TYPE 2 and PREDIABETES. [MeSH]

*Biguanides: Derivatives of biguanide (the structure formula HN(C(NH)NH2)2) that are primarily used as oral HYPOGLYCEMIC AGENTS for the treatment of DIABETES MELLITUS, TYPE 2 and PREDIABETES. [MeSH]

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, Q; Deng, Z; Huai, W; Lin, W1

Other Studies

1 other study(ies) available for di-halo and biguanides

ArticleYear
Enhanced killing of Escherichia coli using a combination of polyhexamethylene biguanide hydrochloride and 1-bromo-3-chloro-5,5- dimethylimidazolidine-2,4-dione.
    FEMS microbiology letters, 2017, Nov-15, Volume: 364, Issue:21

    Topics: Anti-Bacterial Agents; Biguanides; Cell Membrane; Cell Membrane Permeability; Escherichia coli; Hydantoins; Magnesium; Potassium

2017